Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic
Related Experiment Video
Updated: Nov 18, 2025

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Nadine Attal1, Valéria Martinez1,2,3, Didier Bouhassira1,2
1INSERM U 987, CETD, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France.
Abstract:
Although coronavirus disease 2019 (COVID-19) most commonly manifests with acute respiratory symptoms, one very common symptom of COVID-19 is pain. As COVID-19 often causes peripheral or central neurological complications, it is anticipated that a number of the chronic pain complications of COVID-19 will be neuropathic. This review first examines the most common viral infections responsible for neurological complications including neuropathic pain. These encompass herpes zoster, HIV, poliovirus, enteroviruses, and several tropical viruses. Neurological complications of COVID-19 including in particular Guillain-Barré syndrome, myelitis, and stroke are reviewed with regards to their potential risk of chronic neuropathic pain. Prospective longitudinal cohorts of patients should be implemented to evaluate the exact risk of neuropathic pain after COVID-19.
Related Concept Videos
Nociception
Analgesia and Pain Management
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Psychoneuroimmunology: Diabetes and Cancer
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

